Indian vaccine innovation: the case of Shantha Biotechnics
<p>Abstract</p> <p>Background</p> <p>Although the World Health Organization had recommended that every child be vaccinated for Hepatitis B by the early 1980s, large multinational pharmaceutical companies held monopolies on the recombinant Hepatitis B vaccine. At a price...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-04-01
|
| Series: | Globalization and Health |
| Online Access: | http://www.globalizationandhealth.com/content/7/1/9 |